RP
Insider
Raju Prasad
Chief Financial OfficerRaju Prasad (Chief Financial Officer) filed 5 Form 4 reports in the trailing twelve months (0 purchases, 5 sales), most often in CRISPR Therapeutics AG (CRSP). The largest single filing was $2.1M of CRSP (34,972 sh × $60.19, as filed), executed Jan 22.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
5
0 buys · 5 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$5.0M
shares × price, as filed
Last traded
Mar 23
Filed Mar 24
Median ADV $94.8M across their filed names
Open performance→Volume by month
Buys $0
Sells $5.2M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
5 filings
Sector per market data · by filing · past 12 months
Most traded names
CRSPRecent filings
CRSPSALE
CRISPR Therapeutics AG
View filing →
$173K3,708 sh × $46.78
Exec Mar 23
Filed Mar 24 · 5:30 PM ET CRSPSALE CRISPR Therapeutics AG View filing → $476K
9,869 sh across 2 lots
Exec Mar 16
Filed Mar 17 · 5:30 PM ET CRSPSALE CRISPR Therapeutics AG View filing → $2.1M
34,972 sh × $60.19
Exec Jan 22
Filed Jan 26 · 5:30 PM ET CRSPSALE CRISPR Therapeutics AG View filing → $1.8M
29,700 sh across 3 lots
Exec Jan 6
Filed Jan 8 · 5:30 PM ET CRSPSALE CRISPR Therapeutics AG View filing → $503K
9,000 sh across 2 lots
Exec Dec 22 2025
Filed Dec 23 2025 · 5:30 PM ET CRSPSALE CRISPR Therapeutics AG View filing → $157K
3,762 sh × $41.80
Exec Mar 17 2025
Filed Mar 18 2025 · 5:30 PM ET